Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1549941000168111 | blinatumomab 38.5 microgram injection, 38.5 microgram vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1549951000168113 | blinatumomab 38.5 microgram injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| blinatumomab 38.5 microgram injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| blinatumomab 38.5 microgram injection, vial | Is a | blinatumomab | true | Inferred relationship | Some | ||
| blinatumomab 38.5 microgram injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| blinatumomab 38.5 microgram injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1207054613 | |
| blinatumomab 38.5 microgram injection, vial | has Australian BoSS | blinatumomab | true | Inferred relationship | Some | 1207054612 | |
| blinatumomab 38.5 microgram injection, vial | has intended active ingredient | blinatumomab | true | Inferred relationship | Some | 1207054612 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Blincyto (blinatumomab 38.5 microgram) powder for injection, 38.5 microgram vial | Is a | True | blinatumomab 38.5 microgram injection, vial | Inferred relationship | Some | |
| blinatumomab 38.5 microgram injection [1 x 38.5 microgram vial] (&) inert substance solution [1 x 10 mL vial], 1 pack (medicinal product pack) | has MPUU | True | blinatumomab 38.5 microgram injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR